Home › Lymphoma › Minnesota › Rochester
Pag-aaral pangklinika para sa Lymphoma sa Rochester, MN
Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Nagre-recruitPhase 2
- Mayo Clinic in Rochester, Rochester
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Nagre-recruitPhase 3
- Research Site, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Nagre-recruitPhase 1/2
- Mayo Clinic, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
- Mayo Clinic Rochester, Rochester
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- Mayo Clinic, Rochester
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Mayo Clinic in Rochester, Rochester
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Nagre-recruitPhase 2
- Mayo Clinic, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Mayo Clinic, Rochester
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Nagre-recruit
- Mayo Clinic in Rochester, Rochester
Pag-aaral para sa Lymphoma sa ibang lungsod
- Houston, TX34 pag-aaral
- New York City, NY33 pag-aaral
- Boston, MA33 pag-aaral
- Washington, DC23 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Chicago, IL20 pag-aaral
- Durham, NC17 pag-aaral
- Philadelphia, PA15 pag-aaral
- St. Louis, MO15 pag-aaral
- Cleveland, OH13 pag-aaral
- Edison, NJ12 pag-aaral
- Seattle, WA12 pag-aaral
Iba pang pag-aaral sa Rochester
- Kanser sa Suso42 pag-aaral
- Non-Small Cell Lung Cancer37 pag-aaral
- Kanser (lahat ng uri)30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Multiple Myeloma24 pag-aaral
- Kanser sa Pancreas23 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser sa Baga20 pag-aaral
- Kanser ng Endometrium19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.